Management Team / Advisory Board Bios
Howard Doong, M.D., Ph. D.
CEO
Formerly CAP-certified Laboratory Director of Taipei Veteran General Hospital Laboratory of Cancer Genomic Medicine, CEO of Frasergen Genomic Medicine Corp. and Vice President of TrimGen Corporation, a manufacturer of molecular diagnostic reagents and medical instruments. Formerly professor at University of Maryland and researcher at National Institutes of Health (NIH). Ph.D. from The University of Chicago, Department of Organismal Biology and Anatomy; and Department of Surgery. MD/Ph.D. Program, Harvard-MIT Division of Health
Sciences and Technology.*
Dr. T.S. Jiang
Chief Strategy Officer and Director
Currently Chairman of new drug development company BioLite, Inc. As President of PhytoHealth Corporation, led the team that developed and commercialized PG2 Lyo Injection, a new drug to treat cancer related fatigue. Previously director of Taiwan Bio Industry Organization.
Dr. Chi-Hsin Richard King
Chief Scientific Officer
Formerly SVP at pharmaceutical company TaiGen. Formerly Director at Medicinal Chemistry Department at drug discovery and manufacturing company Albany Molecular Research Inc., sold to the Carlyle Group for $1.5B in 2017.
Eugene Jiang
Chairman and interim CFO
Director for new drug development company BioLite Incorporation, and an Executive Officer for Genepro Investment Company.